Aim: The impact of cardiac dysfunction on the liver is known as cardiac hepatopathy. In certain instances this can result in significant hepatic fibrosis or cirrhosis. The validity of non-invasive tools to assess hepatic fibrosis, such as FibroScan(®) which measures liver stiffness (LSM), has not been established in this setting.
View Article and Find Full Text PDFBackground: Living liver donation (LLD) is becoming an accepted way of increasing the donor pool for liver transplantation. The procedure is associated with major ethical difficulties because there is a significant risk of death to the healthy donor.
Methods: We therefore conducted two surveys of the Great Britain population to determine their attitudes to LLD.